CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | de Verneuil Vanina EVP, General Counsel, Corp Sec | Sale 10b5-1 | −2,407 | $11.10 | $27K | 110,193 |
| 2026-11-02 | de Verneuil Vanina EVP, General Counsel, Corp Sec | Sale 10b5-1 | −1,343 | $11.33 | $15K | 112,600 |
| 2026-10-27 | Topalian Suzanne Louise Director | Grant or award | +8,000 | 8,000 | ||
| 2026-10-27 | Topalian Suzanne Louise Director | Grant or award | +4,731 | 12,731 | ||
| 2026-10-27 | Topalian Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2026-10-27 | Topalian Suzanne Louise Director | Grant or award · Stock Option (Right to Buy) | +9,462 | 25,462 | ||
| 2026-08-11 | MORE ROBERT J Director | Other disposition | −8,000 | 40,656 | ||
| 2026-08-11 | MORE ROBERT J Director | Other acquisition | +8,000 | 517,917 | ||
| 2026-06-09 | Coughlin Timothy Director | Grant or award | +8,000 | 8,000 | ||
| 2026-06-09 | Coughlin Timothy Director | Grant or award | +8,000 | 16,000 | ||
| 2026-06-09 | Coughlin Timothy Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2026-06-09 | Coughlin Timothy Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2026-06-01 | Napolitano Janet Director | Sale 10b5-1 | −3,200 | $9.45 | $30K | 21,216 |
| 2026-06-01 | Sabatini Brent SVP, Chief Accounting Officer | Sale 10b5-1 | −379 | $9.45 | $4K | 61,902 |
| 2026-05-27 | Sigal Charles Elliott Director | Grant or award | +8,000 | 39,806 | ||
| 2026-05-27 | Sigal Charles Elliott Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2026-05-27 | Napolitano Janet Director | Grant or award | +8,000 | 24,416 | ||
| 2026-05-27 | Napolitano Janet Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2026-05-27 | MORE ROBERT J Director | Grant or award | +8,000 | 48,656 | ||
| 2026-05-27 | MORE ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 |
Page 1 of 54 · 1,063 trades